Project snapshot: Development of a stable-side test for Hendra virus
Hendra virus (HeV) is a lethal pathogen of major concern to the equine industry in eastern Australia. Currently, conclusive diagnosis of HeV is only possible...
39 pages
Published: 31 Jul 2002
Author(s): Whalley, J. Millar, Love, Daria N.
Download report PDF
DownloadPurchase a hard copy - AUD $45.00
The report details the results of large scale serological surveys of the prevalence of antibody to EHV-1 and compares this 2000 data with that of 1995, obtained prior to vaccination. Secondly by using similar serological analysis and sampling mares and foals intensively over time, the percentage of mares and foals that respond to vaccination in the field was determined. Thirdly, new subunit vaccines based on virus protein or DNA were assessed for ability to induce antibody responses against EHV-1, and the results compared with those of the currently used whole virus vaccine. The development of new vaccines may offer extra protection against EHV-1 or EHV-4 disease and also provide the possibility of import replacement and export potential.